Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: J Pain Symptom Manage. 2017 Dec 6;55(3):792–797. doi: 10.1016/j.jpainsymman.2017.11.028

Table 1.

Patient characteristics (N=215)

Characteristics N (%)1
Age, average (range) 54.9 (22 – 79)
Sex
 Female 126 (58.6)
 Male 89 (41.4)
Ethnicity
 White 142 (66.1)
 Black 43 (20)
 Hispanic 28 (13)
 Others 2 (0.9)
Education
 High school or lower 114 (53)
 College 72 (33.5)
 Advanced 29 (13.5)
Cancer
 Breast 27 (12.6)
 Gastrointestinal 70 (32.6)
 Genitourinary 19 (8.8)
 Gynecological 23 (10.7)
 Head and neck 10 (4.7)
 Hematological 12 (5.6)
 Others 18 (8.4)
 Respiratory 36 (16.7)
Overall survival in days, median (95% confidence interval) 109 (71–133)
Clinician prediction of survival (CPS) in days, median (Q1-Q3) 90 (60–150)
Palliative prognostic index (PPI score)
 0 – 4 points 160 (74.4)
 4.5 – 6 points 38 (17.7)
 6.5 – 15 points 17 (7.9)
PPS in PPI, average (range) 55.7 (20 – 90)
Oral intake in PPI
 Normal 69(32.1)
 Moderately reduced 96(44.7)
 Severely reduced 50(23.3)
Edema in PPI
 Absent (0 point) 160 (74.4)
 Present (1 point) 55 (25.6)
Dyspnea rest in PPI
 Absent (0 point) 188 (87.4)
 Present (1 point) 27 (12.6)
Delirium in PPI
 Absent (0 point) 215 (100)
 Present (1 point) 0

CPS, clinician prediction of survival; PPI, palliative prognostic index

1

unless otherwise specified